Bioprocessing - Upstream & Downstream

Antibody drug conjugates have not yet lived up to their potential, but there is hope – if we turn to the right solutions and techniques.

The challenge of convincing senior staff to invest in continuous bioprocessing.

Gene and Eva discuss the importance of being cautious when choosing a new supplier.

Now is the time to push bioprocess efficiencies even further...

In chromatography, we must continually strive to improve productivity, quality and overall process economy.

Are we entering a new era of continuous bioprocessing? Pall’s experts discuss the opportunities and challenges ahead.

We speak with four experts to gain a fresh perspective on biopharmaceutical characterization.

Looking to advance in the exciting area of cell therapy?

Why embracing single use could help you hedge your bets…